Can Epilepsy Cause Dementia? The Link Explained

Epilepsy roughly doubles to quadruples the risk of developing dementia later in life, depending on the type of epilepsy, the age it begins, and whether seizures are well controlled. The relationship between the two conditions runs deeper than many people realize, and it flows in both directions: epilepsy raises the odds of dementia, and dementia raises the odds of developing seizures. Understanding why requires looking at how repeated seizure activity reshapes the brain over time, how the two conditions share underlying biology, and what can be done to reduce the risk.

How Strong Is the Epidemiological Evidence?

Several large population studies have quantified the link. In the Framingham Heart Study, people with epilepsy had roughly twice the risk of developing dementia compared with matched controls who were seizure-free.¹ That twofold increase is meaningful, but other studies have found even higher numbers. In the Atherosclerosis Risk in Communities (ARIC) cohort, about 42% of people with late-onset epilepsy went on to develop dementia, compared with roughly 17% of those without epilepsy. The adjusted risk was about three times higher for the epilepsy group.² The median time between epilepsy diagnosis and dementia diagnosis in that study was under four years, which raises important questions about whether the epilepsy itself was an early marker of brain degeneration already underway.

A study published in JAMA Neurology found the risk was even steeper for focal epilepsy specifically. Adjusted for other factors, people with focal epilepsy had about four times the risk of developing dementia. That risk surpassed even stroke, which carried about two and a half times the risk in the same analysis.³ These are not small effects. To put the fourfold figure into perspective, it sits in the same range as some of the strongest known risk factors for dementia.

The Relationship Runs Both Ways

One of the trickiest aspects of interpreting these numbers is that dementia itself dramatically increases seizure risk. A large UK study found that Alzheimer’s disease raised the risk of developing seizures more than fivefold, and vascular dementia did the same.⁴ So when a person develops epilepsy in their sixties or seventies and then receives a dementia diagnosis a few years later, it can be genuinely difficult to tell which condition came first. In some cases, the seizures may be one of the earliest clinical signs that neurodegeneration has already begun. In other cases, the seizures themselves may be contributing to the cognitive decline. And in many people, the truth is probably both at once.

This bidirectional relationship complicates research. Observational studies can show that the two conditions travel together, but they cannot always untangle cause from effect. The strongest evidence that seizures themselves contribute to cognitive decline comes from mechanistic research showing how seizure activity damages brain tissue and from studies tracking cognitive trajectories before and after epilepsy diagnosis.

How Seizures Damage the Brain Over Time

Seizures are not just electrical storms that pass without consequence. Several biological mechanisms explain how repeated seizure activity can erode brain function over years and decades.

The most well-established mechanism involves glutamate, the brain’s primary excitatory chemical messenger. During a seizure, neurons fire rapidly and release excessive amounts of glutamate. When glutamate concentrations climb too high, they over-stimulate receiving neurons and trigger cascades that can kill brain cells outright.⁵ This process is especially damaging in the hippocampus, the brain region most critical for forming new memories. Animal research has shown that seizure activity in older brains destroys far more hippocampal neurons than the same activity in younger brains. In one study, older animals lost about 56% of a key hippocampal cell population after acute seizures, compared with 12% in younger animals.⁶ That age-related vulnerability helps explain why late-onset epilepsy is so strongly tied to dementia.

Seizures also disrupt the blood-brain barrier, the tightly sealed lining of blood vessels in the brain that normally prevents harmful substances from leaking into brain tissue. Both clinical and animal studies have documented increased blood-brain barrier leakage during epilepsy, affecting pathways tied to inflammation and oxidative stress.⁷ When that barrier becomes leaky, inflammatory molecules and blood-borne proteins gain access to brain tissue, fueling further damage.

Seizures and the Proteins Behind Alzheimer’s Disease

Perhaps the most alarming discovery in recent years is that seizure activity appears to accelerate the same protein abnormalities seen in Alzheimer’s disease. Tau protein, which normally helps stabilize the internal scaffolding of neurons, becomes chemically altered and clumps together in Alzheimer’s brains. Research in animal models of epilepsy has shown that seizure activity triggers abnormal tau modifications and activates the pathway that produces amyloid beta, the other hallmark protein of Alzheimer’s. These changes were prominent in the hippocampus and persisted for weeks after seizures.⁸

Human tissue studies have pointed in the same direction. Examinations of brain tissue from people with drug-resistant epilepsy have found tau pathology that raises the possibility that seizures can accelerate neurodegenerative processes.⁹ This does not mean epilepsy causes Alzheimer’s disease in the traditional sense. But it suggests the two conditions share overlapping molecular machinery, and that seizure activity may push the brain down a path that looks increasingly like neurodegeneration even when Alzheimer’s was not the original trigger.

You Do Not Need a Full Seizure to Lose Memory

Visible seizures are only part of the story. Between seizures, the brains of people with epilepsy often produce brief electrical bursts called interictal epileptiform discharges. These are too small to cause noticeable symptoms but are common enough to show up on routine brain monitoring. They also appear in people with Alzheimer’s disease who have never been diagnosed with epilepsy.

These subclinical bursts are not harmless. In a study of people with epilepsy undergoing memory testing while their brain activity was being recorded, each burst that occurred in the hippocampus during memory encoding reduced the odds of remembering by about 15%. Bursts during recall were worse, reducing the odds by about 25%. When bursts hit during a critical window of memory formation, the odds of remembering dropped by as much as half.¹⁰ Mouse research has reinforced these findings: in an Alzheimer’s disease model, these discharges correlated inversely with daily memory performance, suggesting they represent a common mechanism of memory disruption across both epilepsy and neurodegeneration.¹¹

The practical implication is striking: a person with epilepsy can experience ongoing memory erosion even when their seizures appear to be controlled, because these subclinical electrical events may continue. Treating only visible seizures may not be enough to protect cognition.

Which Types of Epilepsy Carry the Most Risk

Not all epilepsy is created equal when it comes to dementia risk. The evidence consistently points to temporal lobe epilepsy as the most cognitively dangerous form, which makes sense given that the temporal lobe houses the hippocampus and other structures essential for memory. People with temporal lobe epilepsy caused by hippocampal scarring show deficits in everyday memory tasks including recalling names, recognizing objects, remembering stories, and orienting themselves in time and space.¹² The density of surviving neurons in a specific hippocampal subregion called CA1 predicts how severe the memory impairment will be.¹³

Late-onset epilepsy, which begins after age 60, carries especially high dementia risk. In the ARIC study, people who developed late-onset epilepsy showed cognitive decline equivalent to aging roughly six and a half extra years over a 25-year period compared with people without epilepsy.¹⁴ Some of that decline was detectable before the seizures even started, reinforcing the idea that late-onset epilepsy and dementia may share an underlying cause in at least some people.

At the other end of the age spectrum, epilepsy in early childhood also carries significant cognitive risk. Children with epilepsy were about ten times more likely than age-matched controls to have a cognitive impairment diagnosis, and the risk was highest when seizures started before age two.¹⁵ The developing brain is particularly vulnerable to disruption, and early seizures can derail cognitive growth in ways that persist into adulthood.

Anti-Seizure Medications and Cognition

Here is where the picture gets muddled for patients. The medications used to control seizures can themselves contribute to cognitive problems, creating a frustrating paradox: you need the drugs to stop seizures from damaging your brain, but the drugs have their own cognitive costs. Sedation is the most common cognitive side effect across most anti-seizure medications, and it tends to drag down attention, processing speed, and alertness.¹⁶

Long-term use of anti-seizure drugs has been linked to cognitive dysfunction, though disentangling drug effects from the effects of ongoing seizure activity is methodologically challenging.¹⁷ Taking multiple anti-seizure drugs simultaneously and using high doses are the clearest risk factors for medication-related cognitive harm. Newer-generation drugs generally have milder cognitive side effects than older ones, though individual responses vary. The key point for patients is that cognitive complaints should not be dismissed as an inevitable feature of epilepsy; sometimes they are a signal to revisit the medication regimen.

The APOE ε4 Connection

Genetics add another layer. The APOE ε4 gene variant is the strongest known genetic risk factor for Alzheimer’s disease, and it also turns up more frequently in people with epilepsy. A meta-analysis found that carrying the ε4 variant increased epilepsy risk by about a third, and the association was strongest for temporal lobe epilepsy, drug-resistant epilepsy, and late-onset epilepsy. People with ε4 who had epilepsy tended to have worse cognition and earlier seizure onset.¹⁸

The combination of carrying ε4 and having frequent seizures appears to be especially dangerous. In a study of older adults with epilepsy, having both the ε4 variant and high seizure frequency raised the odds of cognitive impairment more than tenfold compared with people who had neither risk factor.¹⁹ The two risk factors did not just add up; they multiplied each other. For people with epilepsy who know their genetic status, this information could influence how aggressively seizures are managed.

Cardiovascular Risk Compounds Everything

Epilepsy does not exist in a vacuum. The same cardiovascular risk factors that contribute to dementia on their own, including high blood pressure, diabetes, and high cholesterol, appear to amplify the dementia risk of epilepsy substantially. The JAMA Neurology study found that among people with both focal epilepsy and high cardiovascular risk, about 9% developed dementia, compared with 0.4% of low-risk controls without epilepsy. That translates to roughly a fourteenfold difference in risk.³ Late-onset epilepsy frequently coexists with small-vessel cerebrovascular disease, and vascular risk factors have been identified as independent predictors of cognitive problems in this population.²⁰

This is actually encouraging from a prevention standpoint. Unlike your genes or the type of epilepsy you have, cardiovascular risk factors are modifiable. Blood pressure, blood sugar, and cholesterol can all be managed, and doing so may help buffer the brain against the cognitive toll of epilepsy.

Depression, Anxiety, and Sleep

Psychiatric conditions are far more common in people with epilepsy than in the general population, and they carry their own cognitive costs. In a study comparing older adults with epilepsy to matched controls, the epilepsy group scored dramatically worse on cognitive screening and also had substantially higher rates of depression, anxiety, and sleep disruption.²¹ About 18% of the epilepsy group met screening criteria for depression, compared with none of the controls. Poor sleep quality and depression are both independent risk factors for cognitive decline, so when they pile on top of the direct effects of seizures and medication side effects, the cumulative burden on cognition is substantial. Treating comorbid depression and sleep problems may yield cognitive benefits beyond what seizure control alone can accomplish.

Telling Epilepsy-Related Decline Apart from Alzheimer’s

One of the most practically important questions for patients and their families is whether cognitive decline in someone with epilepsy means Alzheimer’s disease is developing. The answer is often no, and emerging biomarker research is making it possible to distinguish the two. A recent study compared people with late-onset temporal lobe epilepsy to people with early Alzheimer’s. Both groups had memory problems, but their brain profiles were remarkably different. The epilepsy group had preserved brain volume on imaging and showed a distinct pattern on spinal fluid biomarkers, with low levels of a nerve damage marker and a characteristic ratio of tau protein subtypes. The Alzheimer’s group, by contrast, showed widespread brain thinning and the typical amyloid and tau abnormalities of the disease.²²

Researchers are actively investigating several biomarkers that could help track neurodegeneration in epilepsy patients, including tau levels in blood and spinal fluid, neurofilament light chain, and various inflammatory markers.²³ These tools are not yet part of standard clinical practice, but they are moving in that direction and could eventually allow doctors to intervene earlier when an epilepsy patient’s cognitive trajectory starts to look worrisome.

Does Cognitive Reserve Offer Any Protection?

The cognitive reserve hypothesis proposes that people who start with a richer cognitive foundation, often reflected in educational attainment and mentally stimulating lifestyles, have a larger buffer against brain damage. There is some evidence this applies to epilepsy. People with higher levels of education maintained better cognitive functioning after developing epilepsy than those with lower educational attainment.²⁴ However, an animal study found that cognitive reserve did not protect against the memory damage caused by severe prolonged seizures, suggesting that there may be a ceiling to what reserve can do once brain injury reaches a certain threshold.²⁵ The mixed evidence suggests that staying mentally active is worthwhile but should not be treated as a substitute for controlling seizures effectively.

Neurostimulation Devices and Cognitive Safety

For people whose seizures resist medication, device-based treatments including vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation have become increasingly common. A natural concern is whether implanting a device that delivers electrical impulses to the brain might make cognitive problems worse. The evidence so far is reassuring. A systematic review found that about half of studies reported stable cognition after chronic stimulation, and more than 40% reported some improvement in at least one cognitive area. Only one study out of nineteen reported decline.²⁶ Deep brain stimulation targeting a specific part of the thalamus has shown particular promise: studies report no significant cognitive decline over years of use, even while reducing disabling seizures by more than half.²⁷ Given that uncontrolled seizures are themselves a major cognitive risk, the calculus for these devices looks favorable.

What Duration and Seizure Frequency Mean for Risk

Not everyone with epilepsy faces the same cognitive future. Research has consistently found that two factors stand out in predicting how badly cognition is affected: how long a person has had epilepsy and how frequently seizures occur. In a study of people over 60 with focal seizures, cognitive impairment across memory, attention, executive function, and language was significantly tied to both the duration of epilepsy and the age at which it started.²⁸ As described in the section on APOE genetics, high seizure frequency on its own roughly tripled the risk of cognitive impairment, and the combination with genetic vulnerability made things far worse.¹⁹

The implication is clear: achieving and maintaining the lowest possible seizure frequency matters not just for quality of life today but for long-term brain health. This is an argument for pursuing aggressive treatment, whether through optimized medication, surgery, or neurostimulation, rather than accepting “good enough” seizure control. For older adults in particular, every seizure avoided may be an investment in preserved cognition years down the road.